News
A new study found that the Worst Itch Numeric Rating Scale is a valid and reliable instrument to capture itch data of patients with prurigo nodularis.“The Worst Itch Numeric Rating Scale (WI ...
Lebrikizumab provided sustained itch relief and improved sleep quality through 52 weeks in individuals with ...
A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...
Patients with moderate to severe atopic dermatitis experienced a 71% decrease in Eczema Area and Severity Index scores from ...
The Skin Pain Numeric Rating Scale, Worst-Itch Numeric Rating Scale, and Dermatology Life Quality Index were evaluated for their content validity, fit-for-purpose, and psychometric and measurement ...
Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...
On presentation, the woman, who was in her 50s, rated the itch as a 10 on the Worst Itch Numeric Rating Scale (range 0-10), Kwatra and colleagues reported in JAMA Dermatology.
Additionally, both roflumilast-treated groups experienced similar improvements in itch-related sleep loss as measured by itch-related sleep loss NRS, which was greater than the vehicle-treated ...
The primary outcome was change in the weekly average of the daily 0 to 10 Worst Itch Numeric Rating Scale, for which 0 is "no itch" and 10 is "worst itch imaginable." ...
INCYTE (INCY): Free Stock Analysis Report This article Incyte Releases Mixed Data From Late-Stage Opzelura Studies In Skin Disease Characterized By Itchy Firm Lumpsoriginally appeared on Benzinga.com ...
Incyte's Phase 3 TRuE-PN trials show ruxolitinib cream improves itch relief in prurigo nodularis, though TRuE-PN2's primary endpoint fell short.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results